Application of platycodon root total saponin in medicaments for treating and preventing mycoplasma pneumoniae infectious diseases
A technology for infectious diseases and Mycoplasma pneumoniae, which is applied to the application field of total saponins from Platycodon grandiflorum in the drug treatment and prevention of Mycoplasma pneumoniae infectious diseases, can solve problems such as affecting economic benefits, long treatment course, and exceeding the standard of antibiotics, so as to avoid exceeding the standard of antibiotics. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0013] Specific embodiment one: the application of the total platycodon saponins in the medicine for the treatment and prevention of Mycoplasma pneumoniae infectious diseases in this embodiment: The total platycodonoid saponins are used as active ingredients in the medicine for the treatment and prevention of Mycoplasma pneumoniae infectious diseases, and the total platycodon saponins are platycodon acids , telegalic acids, bellflower diacids, bellflower acid A lactone saponins or one or more compositions.
[0014] When the total platycodon saponins are composed of two or more substances, they are mixed in any ratio.
[0015] The anti-MP test of Platycodon grandiflora total saponins in vitro is as follows:
[0016] 1 Experimental materials
[0017] The International Standard Strain of Mycoplasma pneumoniae (ATCCFH15531) was purchased from the American Type Culture Collection.
[0018] Platycodon grandiflorum total saponins, laboratory extraction, the total saponin content of...
specific Embodiment approach 2
[0088] Specific embodiment two: the difference between this embodiment and specific embodiment one is that Platycodon grandiflorum total saponins are treated and prevented by oral administration, mucosal administration, respiratory tract administration or injection administration; wherein the treatment and prevention The subjects of the drug are humans and animals with diseases caused by MP infection; the dose for adults is 1-20 mg / Kg body weight, and the dose for animals is 0.5-100 mg / Kg body weight. Others are the same as in the first embodiment.
specific Embodiment approach 3
[0089] Specific embodiment three: the difference between this embodiment and specific embodiment one is that bellflower acids, polygalic acids, bellflower diacids and bellflower A lactone saponins belong to 12-ene-oleanolic acid type pentacyclic triterpenes Saponin, its aglycone chemical general formula is as follows:
[0090]
[0091] Others are the same as in the first embodiment.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com